Is Cameco Stock a Buy Now?

Cameco shares trade near $87, down 35% from their January 28, 2026 record high of $134.09, as uranium spot prices retreated from the mid-$90s and Westinghouse acquisition costs constrained near-term earnings growth. The stock remains valued at roughly 76x current-year earnings despite analysts forecasting 41% EPS CAGR from 2025 to 2028. While nuclear demand supported by decarbonization and AI-related power needs remains a long-term tailwind, projected uranium prices of $98.70/lb by end-2033 imply limited upside versus the current $89.68/lb level and potential valuation risk.

Analysis

CCJ is less a uranium-beta vehicle than the market is pricing it as. Its contract book should dampen both downside and near-term upside from spot moves, while renewal pricing creates a delayed earnings lever; the key 1-3 month question is whether investors stop marking the equity to uranium spot and begin valuing contracted cash flow plus Westinghouse separately. This makes the current drawdown potentially less informative about intrinsic earnings than for NXE, UEC, or URA constituents, but also means a spot-price rebound alone may not close the valuation gap.

The underappreciated asset is the fuel-cycle stack: conversion, enrichment technology exposure, and Westinghouse services address the bottleneck utilities face after securing ore. If Western utilities prioritize non-Russian fuel supply chains, CCJ/BAM's Westinghouse ownership could earn a higher, more durable multiple than mining EBITDA over 6-18 months; Silex Systems (SILXY) offers higher-beta exposure to that enrichment optionality but carries commercialization and regulatory risk.

Consensus is likely too focused on a linear uranium-price forecast. A stable commodity price can still be constructive if utility contracting shifts from inventory drawdowns to multi-year security-of-supply procurement, but it is not sufficient to justify a premium multiple absent visible contract repricing, Westinghouse margin expansion, or accretive capital allocation. The bearish case is not merely lower uranium: it is a prolonged earnings-recognition lag while mine restarts loosen the physical market and rates remain restrictive, producing further multiple compression.

Near-term downside is most acute around uranium-price weakness, quarterly contract-volume realization, and any delay in Westinghouse synergy/cash-flow disclosures. Thesis invalidation for a tactical long would be sustained uranium below roughly $75/lb combined with lower contracted-volume or pricing guidance; upside confirmation would be incremental long-term utility awards, improving Westinghouse backlog conversion, and evidence that enrichment capacity commands scarcity pricing.

Key Decisions for Investors

• Do not chase CCJ on a uranium-spot bounce. Build only a starter position after the next earnings release if contracted sales volumes/pricing and Westinghouse cash-flow guidance are reaffirmed; target a 6-12 month rerating driven by earnings visibility, with exit discipline if uranium remains below ~$75/lb and management cuts delivery or cash-flow expectations.
• Express a relative-value view rather than outright uranium beta: long CCJ / short URA in equal uranium-factor-adjusted dollars for 6-12 months. The thesis is that fuel-cycle and reactor-services exposure should outperform a basket dominated by higher-cost, spot-sensitive miners if utility contracting remains robust; close if CCJ's Westinghouse margins/backlog fail to improve over two reporting periods.
• For higher-risk fuel-cycle optionality, place SILXY on a watchlist rather than initiate immediately. Enter only following independently verified licensing, customer commitments, or financing milestones for enrichment deployment; commercialization slippage and dilution are likely to dominate equity performance before revenue is visible.
• Maintain BAM as the cleaner diversified beneficiary of Westinghouse optionality, but treat it as a modest positive catalyst rather than a nuclear pure-play. Reassess after BAM reports capital deployment and fee-related earnings contribution from its infrastructure platform; the nuclear stake is unlikely to materially move BAM absent a valuation event or distribution.